Want to see TSE:CRON full AI Analyst Report?
CRON Stock Chart & Stats
C$4.95
C$0.09(2.27%)
At close: 4:00 PM EDT
C$4.95
C$0.09(2.27%)
Day’s Range― - ―
52-Week RangeC$3.23 - C$4.99
Previous CloseN/A
Volume145.76K
Average Volume (3M)147.87K
Market Cap
C$1.78B
Enterprise ValueC$410.50
Total Cash (Recent Filing)C$797.02M
Total Debt (Recent Filing)C$1.29M
Price to Earnings (P/E)18.2
Beta1.20
Next Earnings
Nov 11, 2026EPS Estimate
0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.19
Shares Outstanding368,412,870
10 Day Avg. Volume112,372
30 Day Avg. Volume147,873
Financial Highlights & Ratios
PEG Ratio0.83
Price to Book (P/B)0.92
Price to Sales (P/S)6.74
P/FCF Ratio6.63K
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$6.00Price Target Upside21.21% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.15
Revenue Forecast (FY)C$199.00M
Bulls Say, Bears Say
Bulls Say
Revenue And EBITDA GrowthThe sharp revenue rebound and record adjusted EBITDA indicate stronger demand, improved operating leverage, and better execution across the business. If maintained, this momentum can support reinvestment, strengthen brand distribution, and improve the company’s ability to generate durable earnings over the next several quarters.
Conservative Balance Sheet And LiquidityExtremely low leverage and substantial liquidity give Cronos meaningful resilience in a capital-intensive, regulated industry. The company can fund growth, absorb volatility, and pursue strategic opportunities without relying heavily on new borrowing, while positive operating cash flow further improves financial flexibility.
Brand Strength And International ExpansionSpinach’s outperformance and strong international growth suggest Cronos is gaining share through differentiated brands and broader geographic distribution. Leadership across several Canadian product categories, combined with traction in Germany and other markets, can create a stronger platform for sustained revenue expansion.
Bears Say
Profitability Remains InconsistentThe turnaround has not yet translated into consistently positive bottom-line earnings. A slightly negative TTM net margin and recent operating losses indicate that improved revenue and gross profit may still be vulnerable to expenses, mix, or other adjustments, leaving the durability of reported profitability unproven.
Gross Margin VolatilityMargin performance depends partly on changing product and geographic mix as well as seasonal cultivation conditions, which can make earnings less predictable. Even with a strong TTM gross margin, recurring quarter-to-quarter variability could complicate planning and limit the consistency of cash generation.
Israel Regulatory InvestigationThe investigation creates a structural regulatory risk in an important growth market where Cronos Israel has delivered repeated record quarters. Potential changes to import conditions or market access could affect competitive dynamics, pricing, and the returns on the company’s investments in Israel.
Cronos Group News
CRON FAQ
What was Cronos Group’s price range in the past 12 months?
Cronos Group lowest stock price was C$3.23 and its highest was C$4.99 in the past 12 months.
What is Cronos Group’s market cap?
Cronos Group’s market cap is C$1.78B.
When is Cronos Group’s upcoming earnings report date?
Cronos Group’s upcoming earnings report date is Nov 11, 2026 which is in 46 days.
How were Cronos Group’s earnings last quarter?
Cronos Group released its earnings results on Aug 06, 2026. The company reported C$0.127 earnings per share for the quarter, beating the consensus estimate of C$0.014 by C$0.113.
Is Cronos Group overvalued?
According to Wall Street analysts Cronos Group’s price is currently Undervalued.
Does Cronos Group pay dividends?
Cronos Group does not currently pay dividends.
What is Cronos Group’s EPS estimate?
Cronos Group’s EPS estimate is 0.04.
How many shares outstanding does Cronos Group have?
Cronos Group has 368,412,870 shares outstanding.
What happened to Cronos Group’s price movement after its last earnings report?
Cronos Group reported an EPS of C$0.127 in its last earnings report, beating expectations of C$0.014. Following the earnings report the stock price went up 13.684%.
Which hedge fund is a major shareholder of Cronos Group?
Currently, no hedge funds are holding shares in TSE:CRON
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Cronos Group Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
C$6.00 (21.21% Upside)
C$6.00 (21.21% Upside)
Blogger Sentiment
Bullish
TSE:CRON Sentiment 86%
Sector Average 63%
Sector Average 63%
Crowd Wisdom
Very Negative
Last 7 Days ▲ 0.3%
Last 30 Days ▼ 2.4%
Last 30 Days ▼ 2.4%
Technicals
SMA
Positive
20 days / 200 days
Momentum
22.50%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
0.39%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Cronos Group
Cronos Group Inc. functions as a diversified global cannabinoid enterprise. Within the United States, it manufactures, promotes, and distributes a variety of hemp-derived supplements and cosmetic products. These items are available under its Lord Jones and Happy Dance brands through online sales, traditional retail, and hospitality partner networks. The company also plays a significant role in the cultivation, production, and commercialization of cannabis and cannabis-infused products for both medicinal and adult-use sectors. Its comprehensive product offerings encompass dried cannabis flower, pre-rolled joints, edibles, concentrated forms, and cannabis extracts. These are distributed via wholesale partnerships and direct-to-consumer channels, prominently featuring its wellness platform, PEACE NATURALS, and its adult-use brand, Spinach. Moreover, Cronos Group exports dried cannabis and cannabis oils to international markets including Germany, Israel, and Australia. Established in 2012, the company maintains its corporate headquarters in Toronto, Canada.
CRON Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed a broadly positive operational and financial picture: record revenue, gross profit, and adjusted EBITDA, strong brand performance (notably Spinach), meaningful international growth (Israel and Germany), and a robust cash position. Key risks and headwinds include a new anti-dumping investigation in Israel, modest OpEx increases, margin variability tied to seasonality and mix, and timing uncertainty around the CanAdelaar closing. On balance, the positive operational momentum and strong financials outweigh the highlighted risks.View all TSE:CRON earnings summariesCRON Stock 12 Month Forecast
Average Price Target
C$6.00
▲(21.21% Upside)